Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
10/2006
10/03/2006US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes
10/03/2006US7115630 Metabotropic glutamate receptor antagonists
10/03/2006US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties
10/03/2006US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS
09/2006
09/28/2006US20060217534 Bis (amino acid) molecular scaffolds
09/28/2006US20060217416 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents
09/28/2006CA2602151A1 Piperidinyl substituted cyclohexane-1,4-diamines
09/27/2006EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists
09/27/2006CN1839132A N3-substituted imidazopyridine-derivatives as C-KIT inhibitors
09/27/2006CN1276921C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics
09/26/2006US7112683 Cyclic sulfone containing retroviral protease inhibitors
09/21/2006WO2006098855A2 Processes for preparing morphinans and intermediates thereof
09/21/2006US20060211723 Aporphine and oxoaporphine compounds and pharmaceutical use thereof
09/21/2006US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity
09/21/2006US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
09/21/2006US20060211029 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability
09/21/2006CA2600687A1 Processes for preparing morphinans and intermediates thereof
09/20/2006EP1373213B1 A process for the synthesis of an annulated pyridine base
09/20/2006EP1343780B1 Piperazine derivatives for treatment of bacterial infections
09/20/2006EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives
09/20/2006CN1834097A Method of producing 10-hydroxy camptothein
09/20/2006CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor
09/20/2006CN1275965C Derivatives of variolin b
09/20/2006CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
09/19/2006US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections.
09/19/2006US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects
09/19/2006US7109327 Oxidizing agent mixed with a support starting from 8-methoxy-3,4,4a,8a-tetrahydro-spiro-chromen-2-one-[4,4']-cyclohex-2',5'-dien-1'-one to a spirodienone yields 1.6 (+-)-11-oxonarwedine or (+-)-6-methoxy-10-methyl-galantham-1-ene-3,11-dione; treating Alzheimer's disease
09/14/2006WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
09/14/2006WO2006095009A1 Amido-substituted 6-phenylphenanthridines
09/14/2006WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
09/14/2006US20060205760 Molecules and methods for fluorescence microscopy
09/14/2006US20060204587 Use of film coating as taste-masking coating of oral dosage forms
09/14/2006CA2599368A1 Amido-substituted 6-phenylphenanthridines
09/13/2006EP1699803A1 Novel compounds
09/13/2006EP1699791A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
09/13/2006EP1699450A2 Co-administration of dopamine-receptor binding compounds
09/13/2006CN1830965A Method for preparing bicycloenyl lactan
09/12/2006US7105702 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
09/12/2006US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
09/12/2006US7105531 Tricyclic protein kinase inhibitors
09/12/2006US7105513 Cardiovascular disorders; strokes; hypotensive agents
09/12/2006CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders
09/08/2006WO2006093677A1 Tetracyclic sulfonamide compounds and methods of use thereof
09/08/2006WO2006093667A1 Tetracyclic amino and carboxamido compounds and methods of use thereof
09/08/2006WO2005086700A3 Hiv integrase inhibitors
09/08/2006CA2598647A1 Tetracyclic amino and carboxamido compounds and methods of use thereof
09/08/2006CA2597576A1 Isoquinoline compounds and methods of use thereof
09/07/2006DE102005010000A1 Indane Indanes
09/06/2006EP1697327A1 Insecticidal spiroindane derivatives
09/06/2006CN1829689A Benzylamine derivative
09/06/2006CN1829519A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
09/05/2006USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics
09/05/2006US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs
08/2006
08/31/2006WO2006031610A3 Bicyclic anilide spirolactam cgrp receptor antagonists
08/30/2006EP1603907B1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors
08/30/2006EP1543002B1 Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates
08/30/2006EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof
08/30/2006EP1318811B1 Cyclopentyl modulators of chemokine receptor activity
08/30/2006CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use
08/30/2006CN1272324C Novel herbicides
08/30/2006CN1272322C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/29/2006US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents
08/24/2006WO2006088080A1 CYCLOHEPTA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
08/24/2006WO2006086921A1 A process for the preparation of clopidogrel
08/24/2006WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors
08/24/2006WO2006052430A3 Opiate intermediates and methods of synthesis
08/24/2006WO2006019955A3 Antiviral methods and compositions
08/24/2006WO2006001958A3 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
08/24/2006US20060189645 Novel 6-phenylphenantridines
08/24/2006US20060189641 Novel 6-phenlyphenanthridines
08/24/2006CA2598988A1 Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors
08/23/2006EP1692133A1 Diazabicyclononene derivatives and their use as renin inhibitors
08/23/2006EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/23/2006CN1821247A Camptothecine derivatives and their use
08/23/2006CN1821245A Camptothecine derivative and its preparation
08/23/2006CN1271074C Ramification of chirality multi ring quinoline tetroxide, preparation method and usage
08/23/2006CN1271073C Crystalline anti-cholinergic tiotropium crystal
08/23/2006CN1271072C Process for the preparation of 14-hydroxymorphine derivatives
08/22/2006US7094788 A tropane ester derivative for treating asthma, chronic obstractive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal or urinary tracts, and menstrual pain
08/17/2006US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers
08/17/2006US20060183870 Triamantane diamondoid nucleus
08/17/2006US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications
08/16/2006EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1820000A A method for the preparation of enantiomerically pure mirtazapine
08/16/2006CN1817864A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/16/2006CN1269807C Aryl substituted piperazine for curing benign prostatauxe
08/15/2006US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
08/15/2006US7091352 Antiinflammatory agents; analgesics; antiarthritic agents
08/15/2006US7091217 Chemokine receptor binding heterocyclic compounds
08/15/2006US7091212 Chiral dinapsoline
08/10/2006WO2006058778A3 Luminescent indicator dye and optical sensor
08/10/2006US20060178362 Substituted heterocyle fused gamma-carbolines
08/09/2006EP1688418A2 Chemokine receptor antagonists and methods of use thereof
08/09/2006EP1687311A1 Novel compounds
08/09/2006EP1687307A2 Substituted imidazo ring systems and methods
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 110